Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Mitch Dowsett?

Mitch Dowsett

Professor of Biochemical Endocrinology

Institute of Cancer Research

HQ Phone:  +44 20 8722 4253

Direct Phone: +44 ** **** ****direct phone

Email: m***@***.uk

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Institute of Cancer Research

Sir Richard Doll Building15 Cotswold Road

Sutton, Greater London,SM2 5NG

United Kingdom

Company Description

The ICR, London, is one of the world's most influential cancer research organizations. Scientists and clinicians at ICR are working every day to make a real impact on cancer patients' lives. Through its unique partnership with The Royal Marsden NHS Foundation ... more.

Find other employees at this company (5,826)

Background Information

Employment History

Founding Chairman

National Cancer Research Institute


Affiliations

Radius Health, Inc.

Oncology Advisory Board Member


ASCO/CAP

Member of the Steering Committees


Executive and/or Steering Committees

Committees


Immunovia AB

Advisory Board Member


Breast Cancer Update

Member of the Executive Board


ATAC

Member of the Steering and Executive Committees of Several Prominent International Breast Cancer Trials


American Society of Clinical Oncology

Member of the Special Awards Committee


HERA Trial

Member of the Executive Committee


Aromatase Inhibitor Overview Group

Planning Committee


Wales Cancer Bank

Advisory Board Member


NTRAC Translational

Chairman of the Research Committee


Steering Committee

Member


NanoString Technologies Inc

Member


Breast International Group

Executive Committee


Education

BSc

Imperial College


PhD

Chester Beatty Cancer Research Institute at London University


PhD

Institute of Cancer Research


Web References(174 Total References)


radiuspharm.com

Mitch Dowsett, PhD, FMedSci
Mitch Dowsett, PhD, FMedSci Mitch Dowsett, PhD, FMedSci, is a clinical scientist who has over 540 papers listed on PubMed. He is Head of the Academic Department of Biochemistry and of the Centre for Molecular Pathology at the Royal Marsden Hospital. He is Professor of Biochemical Endocrinology at the Institute of Cancer Research and of Translational Research in the Breakthrough Breast Cancer Centre in London, UK. His major research interests involve hormonal aspects of breast cancer and the application of biomarkers in clinical trials. He was a major player in the development of aromatase inhibitors, now the most widely used endocrine agent for postmenopausal breast cancer patients and chairs the Aromatase Inhibitor Overview Group that co-ordinates the collaborative assessment of the merged data from the international trials. He is a member of the ASCO/CAP Steering Committees for guidelines on both HER2 and steroid receptors and he co-chairs the International Working Group on Ki67 in Breast Cancer. He was the founding chairman of the National Cancer Research Institute's Biomarker and Imaging Clinical Study Group. Professor Dowsett is particularly interested in the evaluation of new and established agents in presurgical studies of breast cancer including being co-PI of the 4,450 patient POETIC trial, the largest study conducted to date. He sits on the Executive and/or Steering Committees of many international trials and served for 7 years on the Executive Committee of the Breast International Group (BIG). Mitch Dowsett, PhD, FMedSci Mitch Dowsett, PhD, FMedSci Mitch Dowsett, PhD, FMedSci Mitch Dowsett, PhD, FMedSci Mitch Dowsett, PhD, FMedSci, is a clinical scientist who has over 540 papers listed on PubMed. He is Head of the Academic Department of Biochemistry and of the Centre for Molecular Pathology at the Royal Marsden Hospital. He is Professor of Biochemical Endocrinology at the Institute of Cancer Research and of Translational Research in the Breakthrough Breast Cancer Centre in London, UK. His major research interests involve hormonal aspects of breast cancer and the application of biomarkers in clinical trials. He was a major player in the development of aromatase inhibitors, now the most widely used endocrine agent for postmenopausal breast cancer patients and chairs the Aromatase Inhibitor Overview Group that co-ordinates the collaborative assessment of the merged data from the international trials. He is a member of the ASCO/CAP Steering Committees for guidelines on both HER2 and steroid receptors and he co-chairs the International Working Group on Ki67 in Breast Cancer. He was the founding chairman of the National Cancer Research Institute's Biomarker and Imaging Clinical Study Group. Professor Dowsett is particularly interested in the evaluation of new and established agents in presurgical studies of breast cancer including being co-PI of the 4,450 patient POETIC trial, the largest study conducted to date. He sits on the Executive and/or Steering Committees of many international trials and served for 7 years on the Executive Committee of the Breast International Group (BIG).


www.icr.ac.uk [cached]

Professor Mitch Dowsett's Endocrinology Team aims to translate basic breast cancer research into advances in patient care.
Team leader Professor Mitch Dowsett Professor Mitch Dowsett  Professor of Biochemical Endocrinology Professor Mitch Dowsett's studies into the role of hormones in breast cancer have led to the clinical development of aromatase inhibitors. He holds membership to several senior committees and is on the executive committees for several clinical trials.


www.radiuspharm.com

Mitch Dowsett, PhD, FMedSci
Mitch Dowsett, PhD, FMedSci Mitch Dowsett, PhD, FMedSci, is a clinical scientist who has over 540 papers listed on PubMed. He is Head of the Academic Department of Biochemistry and of the Centre for Molecular Pathology at the Royal Marsden Hospital. He is Professor of Biochemical Endocrinology at the Institute of Cancer Research and of Translational Research in the Breakthrough Breast Cancer Centre in London, UK. His major research interests involve hormonal aspects of breast cancer and the application of biomarkers in clinical trials. He was a major player in the development of aromatase inhibitors, now the most widely used endocrine agent for postmenopausal breast cancer patients and chairs the Aromatase Inhibitor Overview Group that co-ordinates the collaborative assessment of the merged data from the international trials. He is a member of the ASCO/CAP Steering Committees for guidelines on both HER2 and steroid receptors and he co-chairs the International Working Group on Ki67 in Breast Cancer. He was the founding chairman of the National Cancer Research Institute's Biomarker and Imaging Clinical Study Group. Professor Dowsett is particularly interested in the evaluation of new and established agents in presurgical studies of breast cancer including being co-PI of the 4,450 patient POETIC trial, the largest study conducted to date. He sits on the Executive and/or Steering Committees of many international trials and served for 7 years on the Executive Committee of the Breast International Group (BIG). He has received the William L. McGuire Award and the Brinker Award for Scientific Distinction and has given multiple named lectures.


immunovia.com

Prof. Mitch Dowsett
Head of the Academic Department of Biochemistry and Head of Breast Cancer Translational Research, Royal Marsden Hospital and Institute of Cancer Research, London, England


www.thejakartapost.com

"But aromatase inhibitor treatment is not free of side-effects and it's important to ensure that women" who suffer them are "supported", said the study's lead author, Mitch Dowsett of The Institute of Cancer Research in London.


Similar Profiles

Other People with this Name

Other People with the name Dowsett

Robyn Dowsett

Prince Edward-Hastings Conservative Association

Dana Dowsett

Southeast Retail Group

Graeme Dowsett

Vidal O'Brien & Co

Michael Dowsett

MHP Communications

Ian Dowsett

Noroco Investments Pty.Ltd

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory